CSPC PHARMACEUT.GR. ADR4 (CVGU) — Capital Reinvestment Ratio
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Capital Reinvestment Ratio of 0.39x as of December 2025, meaning it reinvests 0% of its operating cash flow (€5.83 Billion) in capital expenditures (€2.28 Billion). See CSPC PHARMACEUT.GR. ADR4 balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CSPC PHARMACEUT.GR. ADR4 Capital Reinvestment Ratio (2021–2025)
This chart tracks CSPC PHARMACEUT.GR. ADR4's Capital Reinvestment Ratio across 5 annual periods. Check total reinvestment intensity of CSPC PHARMACEUT.GR. ADR4 to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year Capital Reinvestment Ratio for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. For live market cap and broader valuation context, see CSPC PHARMACEUT.GR. ADR4 (CVGU) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | €5.83 Billion | €2.28 Billion | ▼ -33.8% |
| 2024 | 0.59x | €4.53 Billion | €2.68 Billion | ▲ +30.4% |
| 2023 | 0.45x | €4.18 Billion | €1.89 Billion | ▲ +26.9% |
| 2022 | 0.36x | €7.63 Billion | €2.72 Billion | ▼ -5.9% |
| 2021 | 0.38x | €4.64 Billion | €1.76 Billion | — |